233 related articles for article (PubMed ID: 26980762)
1. Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.
Zhang X; Guo C; Wu X; Li AX; Liu L; Tsark W; Dammann R; Shen H; Vonderfecht SL; Pfeifer GP
Cancer Res; 2016 May; 76(9):2824-35. PubMed ID: 26980762
[TBL] [Abstract][Full Text] [Related]
2. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.
Guo C; Tommasi S; Liu L; Yee JK; Dammann R; Pfeifer GP
Curr Biol; 2007 Apr; 17(8):700-5. PubMed ID: 17379520
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation.
Li W; Yue F; Dai Y; Shi B; Xu G; Jiang X; Zhou X; Pfeifer GP; Liu L
Cell Death Differ; 2019 Aug; 26(8):1379-1395. PubMed ID: 30315205
[TBL] [Abstract][Full Text] [Related]
7. Mammalian Hippo kinase pathway is downregulated by BCL-2 via protein degradation.
Won GW; Park SH; Park J; Lee Y; Lee YH
Biochem Biophys Res Commun; 2019 Apr; 512(1):87-92. PubMed ID: 30867124
[TBL] [Abstract][Full Text] [Related]
8. SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
Bae SJ; Ni L; Osinski A; Tomchick DR; Brautigam CA; Luo X
Elife; 2017 Oct; 6():. PubMed ID: 29063833
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
10. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
[TBL] [Abstract][Full Text] [Related]
11. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
[TBL] [Abstract][Full Text] [Related]
12. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
[TBL] [Abstract][Full Text] [Related]
13. RAN GTPase is a RASSF1A effector involved in controlling microtubule organization.
Dallol A; Hesson LB; Matallanas D; Cooper WN; O'Neill E; Maher ER; Kolch W; Latif F
Curr Biol; 2009 Jul; 19(14):1227-32. PubMed ID: 19559616
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle.
de Amorim ÍSS; de Sousa Rodrigues MM; Mencalha AL
J Cancer Res Clin Oncol; 2021 May; 147(5):1287-1297. PubMed ID: 33580421
[TBL] [Abstract][Full Text] [Related]
15. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
Schmidt ML; Hobbing KR; Donninger H; Clark GJ
Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
[TBL] [Abstract][Full Text] [Related]
18. The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary.
Lyu Z; Qin N; Tyasi TL; Zhu H; Liu D; Yuan S; Xu R
PLoS One; 2016; 11(8):e0160896. PubMed ID: 27505353
[TBL] [Abstract][Full Text] [Related]
19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
20. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
